Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Ghahramani Seno, Mohammad M ^a,b   Trollet, Capucine ^a   Athanasopoulos, Takis ^a   Graham, Ian R ^a,c   Hu, Pingzhao ^b   Dickson, George ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALSEQUESTRIN; CALSEQUESTRIN 1; CONNECTIN; DYSTROPHIN; ION CHANNEL; OBSCURIN; PARVALBUMIN; PHOSPHOTRANSFERASE; TITIN CAP PROTEIN; UNCLASSIFIED DRUG; MICRORNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; CELL POPULATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE CONTROL; GENE EXPRESSION PROFILING; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE METABOLISM; MUSCLE STRESS; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN DEPLETION; RNA INTERFERENCE; SKELETAL MUSCLE; TRANSCRIPTOMICS; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENE LOCUS; GENE SILENCING; GENETICS; HEART MUSCLE; METABOLISM; MUSCLE; PHYSIOLOGY;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DYSTROPHIN; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; GENETIC LOCI; MICE; MICRORNAS; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLES; MYOCARDIUM; PHENOTYPE; RNA INTERFERENCE;

EID: 77952829267     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-345     Document Type: Article

References (73)

1. Emery AEH. Duchenne Muscular Dystrophy. Oxford Monographs on Medical Genetics. 1993, Oxford, UK: Oxford Univ. Press, 2.
2. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984, 81(4):1189-1192. 10.1073/pnas.81.4.1189, 344791, 6583703.
3. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989, 244(4912):1578-1580. 10.1126/science.2662404, 2662404.
4. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51(6):919-928. 10.1016/0092-8674(87)90579-4, 3319190.
5. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003, 2(12):731-740. 10.1016/S1474-4422(03)00585-4, 14636778.
6. Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 2007, 36(1):1-7. 10.1016/j.pediatrneurol.2006.09.016, 17162189.
7. Niebroj-Dobosz I, Fidzianska A, Hausmanowa-Petrusewicz I. Controversies about the function of dystrophin in muscle. Folia Neuropathol 2001, 39(4):253-258.
8. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002, 82(2):291-329.
9. Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 2004, 94(8):1023-1031. 10.1161/01.RES.0000126574.61061.25, 15117830.
10. Boer JM, de Meijer EJ, Mank EM, van Ommen GB, Den Dunnen JT. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice. Neuromuscul Disord 2002, 12(Suppl 1):S118-S124. 10.1016/S0960-8966(02)00092-5, 12206806.
11. Chen YW, Zhao P, Borup R, Hoffman EP. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 2000, 151(6):1321-1336. 10.1083/jcb.151.6.1321, 2190600, 11121445.
12. Haslett JN, Sanoudou D, Kho AT, Han M, Bennett RR, Kohane IS, Beggs AH, Kunkel LM. Gene expression profiling of Duchenne muscular dystrophy skeletal muscle. Neurogenetics 2003, 4(4):163-171. 10.1007/s10048-003-0148-x, 12698323.
13. Noguchi S, Tsukahara T, Fujita M, Kurokawa R, Tachikawa M, Toda T, Tsujimoto A, Arahata K, Nishino I. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 2003, 12(6):595-600. 10.1093/hmg/12.6.595, 12620965.
14. Pescatori M, Broccolini A, Minetti C, Bertini E, Bruno C, D'Amico A, Bernardini C, Mirabella M, Silvestri G, Giglio V, et al. Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J 2007, 21(4):1210-1226. 10.1096/fj.06-7285com, 17264171.
15. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W, Andrade FH. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002, 11(3):263-272. 10.1093/hmg/11.3.263, 11823445.
16. Porter JD, Merriam AP, Leahy P, Gong B, Khanna S. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet 2003, 12(15):1813-1821. 10.1093/hmg/ddg197, 12874102.
17. Rouger K, Le Cunff M, Steenman M, Potier MC, Gibelin N, Dechesne CA, Leger JJ. Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice. Am J Physiol Cell Physiol 2002, 283(3):C773-C784.
18. Tkatchenko AV, Le Cam G, Leger JJ, Dechesne CA. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim Biophys Acta 2000, 1500(1):17-30.
19. Tkatchenko AV, Pietu G, Cros N, Gannoun-Zaki L, Auffray C, Leger JJ, Dechesne CA. Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients. Neuromuscul Disord 2001, 11(3):269-277. 10.1016/S0960-8966(00)00198-X, 11297942.
20. Tseng BS, Zhao P, Pattison JS, Gordon SE, Granchelli JA, Madsen RW, Folk LC, Hoffman EP, Booth FW. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol 2002, 93(2):537-545.
21. Turk R, Sterrenburg E, de Meijer EJ, van Ommen GJ, Den Dunnen JT, t Hoen PA. Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics 2005, 6:98. 10.1186/1471-2164-6-98, 1190170, 16011810.
22. Rao M, Sockanathan S. Molecular mechanisms of RNAi: implications for development and disease. Birth Defects Res CEmbryo Today 2005, 75(1):28-42.
23. Ghahramani Seno MM, Graham IR, Athanasopoulos T, Trollet C, Pohlschmidt M, Crompton MR, Dickson G. RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology. Hum Mol Genet 2008, 17(17):2622-2632. 10.1093/hmg/ddn162, 18511456.
24. Blanco G, Coulton GR, Biggin A, Grainge C, Moss J, Barrett M, Berquin A, Marechal G, Skynner M, van Mier P, et al. The kyphoscoliosis (ky) mouse is deficient in hypertrophic responses and is caused by a mutation in a novel muscle-specific protein. Hum Mol Genet 2001, 10(1):9-16. 10.1093/hmg/10.1.9, 11136708.
25. Agrawal PB, Greenleaf RS, Tomczak KK, Lehtokari VL, Wallgren-Pettersson C, Wallefeld W, Laing NG, Darras BT, Maciver SK, Dormitzer PR, et al. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet 2007, 80(1):162-167. 10.1086/510402, 1785312, 17160903.
26. Thirion C, Stucka R, Mendel B, Gruhler A, Jaksch M, Nowak KJ, Binz N, Laing NG, Lochmuller H. Characterization of human muscle type cofilin (CFL2) in normal and regenerating muscle. Eur J Biochem 2001, 268(12):3473-3482. 10.1046/j.1432-1327.2001.02247.x, 11422377.
27. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995, 81(1):27-40. 10.1016/0092-8674(95)90368-2, 7720071.
28. Moreira ES, Vainzof M, Marie SK, Sertie AL, Zatz M, Passos-Bueno MR. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet 1997, 61(1):151-159. 10.1086/513889, 1715843, 9245996.
29. Moreira ES, Wiltshire TJ, Faulkner G, Nilforoushan A, Vainzof M, Suzuki OT, Valle G, Reeves R, Zatz M, Passos-Bueno MR, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000, 24(2):163-166. 10.1038/72822, 10655062.
30. Nakajima H, Kono N, Yamasaki T, Hotta K, Kawachi M, Kuwajima M, Noguchi T, Tanaka T, Tarui S. Genetic defect in muscle phosphofructokinase deficiency. Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5'-splice site. J Biol Chem 1990, 265(16):9392-9395.
31. Raben N, Sherman JB. Mutations in muscle phosphofructokinase gene. Hum Mutat 1995, 6(1):1-6. 10.1002/humu.1380060102, 7550225.
32. Tarui S, Ikura Y, Tanaka T, Suda M, Nishikawa M. Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenesis. Biochem Biophys Res Commun 1965, 19:517-523. 10.1016/0006-291X(65)90156-7, 14339001.
33. Allard B. Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres. J Muscle Res Cell Motil 2006, 27(5-7):367-373. 10.1007/s10974-006-9083-4, 16874448.
34. Chinet AE, Even PC, Decrouy A. Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal muscles. Experientia 1994, 50(6):602-605. 10.1007/BF01921731, 8020621.
35. Khairallah M, Khairallah R, Young ME, Dyck JR, Petrof BJ, Des RC. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol 2007, 43(2):119-129. 10.1016/j.yjmcc.2007.05.015, 17583724.
36. McClure WC, Rabon RE, Ogawa H, Tseng BS. Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice. Neuromuscul Disord 2007, 17(8):639-650. 10.1016/j.nmd.2007.04.008, 2706264, 17588756.
37. Zhang W, ten Hove M, Schneider JE, Stuckey DJ, Sebag-Montefiore L, Bia BL, Radda GK, Davies KE, Neubauer S, Clarke K. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J Mol Cell Cardiol 2008, 45(6):754-760. 10.1016/j.yjmcc.2008.09.125, 18929569.
38. Dogra C, Changotra H, Wergedal JE, Kumar A. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. J Cell Physiol 2006, 208(3):575-585. 10.1002/jcp.20696, 16741926.
39. Kumar A, Khandelwal N, Malya R, Reid MB, Boriek AM. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 2004, 18(1):102-113. 10.1096/fj.03-0453com, 14718391.
40. Reynolds JG, McCalmon SA, Donaghey JA, Naya FJ. Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy. J Biol Chem 2008, 283(13):8070-8074. 10.1074/jbc.C700221200, 2276392, 18252718.
41. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):3.
42. Huang D, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57. 10.1038/nprot.2008.211, 19131956.
43. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, (36 Database):D154-D158. 2238936, 17991681.
44. Niebroj-Dobosz I, Lukasiuk M. Immunoblot analysis of sarcoplasmic calcium binding proteins in Duchenne muscular dystrophy. J Neurol 1995, 242(2):82-86. 10.1007/BF00887821, 7707095.
45. Sano M, Yokota T, Endo T, Tsukagoshi H. A developmental change in the content of parvalbumin in normal and dystrophic mouse (mdx) muscle. J Neurol Sci 1990, 97(2-3):261-272. 10.1016/0022-510X(90)90224-B, 2119423.
46. Hopf FW, Turner PR, Steinhardt RA. Calcium misregulation and the pathogenesis of muscular dystrophy. Subcell Biochem 2007, 45:429-464. full_text, 18193647.
47. Lucas-Heron B. Muscular degeneration in Duchenne's dystrophy may be caused by a mitochondrial defect. Med Hypotheses 1995, 44(4):298-300. 10.1016/0306-9877(95)90184-1, 7666833.
48. Lucas-Heron B. Absence of a calmitine-specific protease inhibitor in skeletal muscle mitochondria of patients with Duchenne's muscular dystrophy. Biochem Biophys Res Commun 1996, 225(3):701-704. 10.1006/bbrc.1996.1238, 8780677.
49. Paolini C, Quarta M, Nori A, Boncompagni S, Canato M, Volpe P, Allen PD, Reggiani C, Protasi F. Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1. J Physiol 2007, 583(Pt 2):767-784. 10.1113/jphysiol.2007.138024, 2277031, 17627988.
50. Wong W, Scott JD. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 2004, 5(12):959-970. 10.1038/nrm1527, 15573134.
51. Ceccarini M, Grasso M, Veroni C, Gambara G, Artegiani B, Macchia G, Ramoni C, Torreri P, Mallozzi C, Petrucci TC, et al. Association of dystrobrevin and regulatory subunit of protein kinase A: a new role for dystrobrevin as a scaffold for signaling proteins. J Mol Biol 2007, 371(5):1174-1187. 10.1016/j.jmb.2007.06.019, 17610895.
52. Russell MA, Lund LM, Haber R, McKeegan K, Cianciola N, Bond M. The intermediate filament protein, synemin, is an AKAP in the heart. Arch Biochem Biophys 2006, 456(2):204-215. 10.1016/j.abb.2006.06.010, 16934740.
53. Bhosle RC, Michele DE, Campbell KP, Li Z, Robson RM. Interactions of intermediate filament protein synemin with dystrophin and utrophin. Biochem Biophys Res Commun 2006, 346(3):768-777. 10.1016/j.bbrc.2006.05.192, 16777071.
54. Sadoulet-Puccio HM, Rajala M, Kunkel LM. Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc Natl Acad Sci USA 1997, 94(23):12413-12418. 10.1073/pnas.94.23.12413, 24974, 9356463.
55. Reynolds JG, McCalmon SA, Tomczyk T, Naya FJ. Identification and mapping of protein kinase A binding sites in the costameric protein myospryn. Biochim Biophys Acta 2007, 1773(6):891-902. 10.1016/j.bbamcr.2007.04.004, 1955755, 17499862.
56. Dogra C, Srivastava DS, Kumar A. Protein-DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice. Mol Cell Biochem 2008, 312(1-2):17-24. 10.1007/s11010-008-9716-6, 2785438, 18278580.
57. Roy S, Wolff C, Ingham PW. The u-boot mutation identifies a Hedgehog-regulated myogenic switch for fiber-type diversification in the zebrafish embryo. Genes Dev 2001, 15(12):1563-1576. 10.1101/gad.195801, 312718, 11410536.
58. Ogura Y, Naito H, Kakigi R, Ichinoseki-Sekine N, Kurosaka M, Katamoto S. Alpha-actinin-3 levels increase concomitantly with fast fibers in rat soleus muscle. Biochem Biophys Res Commun 2008, 372(4):584-588. 10.1016/j.bbrc.2008.05.059, 18501704.
59. Kurasawa M, Sato N, Matsuda A, Koshida S, Totsuka T, Obinata T. Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles. Muscle Nerve 1999, 22(2):196-207. 10.1002/(SICI)1097-4598(199902)22:2<196::AID-MUS7>3.0.CO;2-E, 10024132.
60. Borisov AB, Sutter SB, Kontrogianni-Konstantopoulos A, Bloch RJ, Westfall MV, Russell MW. Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing. Histochem Cell Biol 2006, 125(3):227-238. 10.1007/s00418-005-0069-x, 16205939.
61. Kontrogianni-Konstantopoulos A, Catino DH, Strong JC, Sutter S, Borisov AB, Pumplin DW, Russell MW, Bloch RJ. Obscurin modulates the assembly and organization of sarcomeres and the sarcoplasmic reticulum. FASEB J 2006, 20(12):2102-2111. 10.1096/fj.06-5761com, 17012262.
62. Fan GC, Chu G, Kranias EG. Hsp20 and its cardioprotection. Trends Cardiovasc Med 2005, 15(4):138-141. 10.1016/j.tcm.2005.05.004, 16099377.
63. Linke WA. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 2008, 77(4):637-648.
64. Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab 2006, 88(1):78-85. 10.1016/j.ymgme.2005.10.008, 2756511, 16352453.
65. Hayashi T, Arimura T, Itoh-Satoh M, Ueda K, Hohda S, Inagaki N, Takahashi M, Hori H, Yasunami M, Nishi H, et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 2004, 44(11):2192-2201. 10.1016/j.jacc.2004.08.058, 15582318.
66. Nakagami H, Kikuchi Y, Katsuya T, Morishita R, Akasaka H, Saitoh S, Rakugi H, Kaneda Y, Shimamoto K, Ogihara T. Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension. Hypertens Res 2007, 30(12):1239-1246. 10.1291/hypres.30.1239, 18344630.
67. Benson MA, Tinsley CL, Blake DJ. Myospryn is a novel binding partner for dysbindin in muscle. J Biol Chem 2004, 279(11):10450-10458. 10.1074/jbc.M312664200, 14688250.
68. Graham IR, Hill VJ, Manoharan M, Inamati GB, Dickson G. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. J Gene Med 2004, 6(10):1149-1158. 10.1002/jgm.603, 15386737.
69. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31(4):e15. 10.1093/nar/gng015, 150247, 12582260.
70. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-193. 10.1093/bioinformatics/19.2.185, 12538238.
71. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24(13):1547-1548. 10.1093/bioinformatics/btn224, 18467348.
72. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. Article3.
73. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.